Form 4: Evolent Health COO Emily Ann Rafferty Sells Shares Under 10b5-1 Plan

Emily Ann Rafferty, Chief Operating Officer of Evolent Health, Inc., sold 8,861 shares of Class A Common Stock on August 22, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On August 22, 2024, Emily Ann Rafferty, the Chief Operating Officer of Evolent Health, Inc. (EVH), sold 8,861 shares of Class A Common Stock.
• The sale was executed at a price of $30 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan adopted on March 8, 2024.
• Following the transaction, Rafferty directly owns 63,408 shares of Evolent Health, Inc.
• This amount includes restricted stock units granted under awards previously reported to the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Sales by company insiders are a common occurrence and are often scrutinized by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, sales under a 10b5-1 plan are less likely to be indicative of management's current sentiment, as these plans are pre-arranged and can be set up for various personal financial planning reasons.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the small volume of shares sold.
• The sale is unlikely to significantly affect employees, customers, suppliers, or creditors.

Key Dates